Targeted Drug Delivery System Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
June 24, 2021 09:22 ET
|
ReportLinker
New York, June 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Targeted Drug Delivery System Market Research Report by Product, by Application, by Region - Global...
CMR Surgical appoints Catherine Moukheibir as Non-Executive Director
January 21, 2021 07:00 ET
|
CMR Surgical
CMR Surgical appoints Catherine Moukheibir as Non-Executive Director Cambridge, UK. 21 January 2021 (00:01 GMT). CMR Surgical (CMR), the Company behind the next-generation surgical robotic system...
CMR Surgical appoints Catherine Moukheibir as Non-Executive Director
January 21, 2021 02:00 ET
|
CMR Surgical
CMR Surgical appoints Catherine Moukheibir as Non-Executive Director Cambridge, UK. 21 January 2021 (00:01 GMT). CMR Surgical (CMR), the Company behind the next-generation surgical robotic system...
Global Nanobiotechnology Industry
September 08, 2020 03:01 ET
|
ReportLinker
New York, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nanobiotechnology Industry" - https://www.reportlinker.com/p04707106/?utm_source=GNW 8...
MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer
August 05, 2020 08:30 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment...
LabGenius Appoints Dr Edwin Moses as Chairman of its Board of Directors
April 20, 2020 07:00 ET
|
LabGenius
LabGenius Appoints Dr Edwin Moses as Chairman of its Board of Directors London, UK 20 April 2020 – LabGenius Ltd (“LabGenius” or “the Company”), a biopharmaceutical company developing...
LabGenius Appoints Dr Edwin Moses as Chairman of its Board of Directors
April 20, 2020 02:00 ET
|
LabGenius
LabGenius Appoints Dr Edwin Moses as Chairman of its Board of Directors London, UK 20 April 2020 – LabGenius Ltd (“LabGenius” or “the Company”), a biopharmaceutical company developing...
Global Cancer Immunotherapy Market Outlook to 2023: Includes Coverage of the Future Impact of CAR-T Therapies
December 16, 2019 12:58 ET
|
Research and Markets
Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Global Cancer Immunotherapy Market Analysis & Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. Within the...
Global Inflammatory Bowel Disease (IBD) Therapeutics Industry
October 11, 2019 03:11 ET
|
ReportLinker FR
New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Inflammatory Bowel Disease (IBD) Therapeutics Industry" -...
Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme
September 10, 2019 07:01 ET
|
Vectura Group plc
Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme Chippenham, UK – 10 September 2019:...